Avalo Therapeutics, Inc. (AVTX) vs TRex Bio Inc. (TRXB)

Avalo Therapeutics, Inc. AVTX 6.95 +4.83%
TRex Bio Inc. TRXB 13.26 +2.08%

Avalo Therapeutics, Inc. and TRex Bio Inc. are both Biotechnology companies. Avalo Therapeutics, Inc. and TRex Bio Inc. are of similar size ($356.5M and $355.6M).

Metric	AVTX	TRXB	Biotechnology median
P/E	n/m	—	10.60
P/S	243.01	—	9.40
P/B	0.68	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	0.94	—	0.66
EV/Sales	(68.78)	—	9.02
Earnings yield	(68.36%)	—	(32.88%)
Free cash flow yield	(45.92%)	—	(23.13%)

Metric	AVTX	TRXB	Biotechnology median
Gross margin	64.72%	—	68.51%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(36.27%)	—	(51.96%)
Return on assets	(32.50%)	—	(46.06%)
Return on invested capital	(118.21%)	—	0.00%

Metric	AVTX	TRXB	Biotechnology median
Revenue growth (TTM)	(92.65%)	—	6.76%
EPS growth (last fiscal year)	72.07%	—	29.88%
Revenue growth, 5-year CAGR	(61.19%)	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	AVTX	TRXB	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	19.31	—	4.97
Net debt to EBITDA	1.36	—	1.01

Metric	AVTX	TRXB	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	AVTX	TRXB	Biotechnology median
Market cap	355.56m	356.52m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack